Please login to the form below

Not currently logged in
Email:
Password:

Anne Prener to lead Freeline Therapeutics

She joins from Gyroscope Therapeutics to take up CEO role

London, UK-based gene therapy-focused biopharmaceutical company Freeline Therapeutics has appointed Anne Prener as its new chief executive officer.

She joins from Gyroscope Therapeutics where she was CEO and brings to her new role experience in drug development and commercialisation with a specific focus on gene therapy and rare diseases.

Frener said: “I am excited to be joining Freeline at this important time in the company’s development as our most advanced programme approaches the clinical proof of concept stage and with our novel pipeline not far behind.

“Freeline comprises some of the world’s leading experts in gene therapy, haemophilia and other debilitating disorders and I look forward to working closely with them to demonstrate the potential of our next-generation AAV gene therapy platform."

Prior to Gyroscope, Frener served as vice president, clinical research haematology and global therapeutic area head of haematology at Baxalta.

She has also worked at Novo Nordisk as senir vice president, haemophilia R&D and was a council member of its Haemophilia Foundation – a non-profit organisation aiming to improve access to care for people with bleeding disorders.

Chris Hollowood, chairman of Freeline Therapeutics and chief investment officer of Syncona, said: “Anne is an extremely accomplished executive with extensive experience in building and leading teams and developing haematology and gene therapy products that positively impact patients’ lives.

“She joins an established team and a company with a strong foundation poised for the next phase of its growth.”

13th July 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

Women in science
The role of women in science and technology
Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
Maria Dahl
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
China secures a place at the forefront of innovative medicine...
Virtual Research Grants Submission and Approval Program
Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....

Infographics